沈阳哪里有算命比较准的繁昌有算卦准的地方吗,淮阴有算卦准的地方吗,慈溪算命的在哪里,上海算命一条街在哪里,云和哪儿算命准,大洼哪里有看的准的看相,织金算命看事哪家准

Lee Keum-seom hasn't held her son in 68 years.The last time she saw him, Sang Chol was four years old, and together with her husband and their daughter, they were headed south, fleeing the fighting during the early days of the Korean War.In the mass of hundreds of thousands of others trying to escape, Lee and her daughter lost sight of her husband and Sang Chol.They continued south, becoming part of the flood of refugees who crossed what became the Demilitarized Zone. Only later did she discover that her husband and son remained on the other side of the divide, in North Korea.They are among the tens of thousands of Koreans whose families were separated by the war.Lee is now one of a small number of people fortunate enough to be chosen for government-run family reunions.On Monday, the first reunion in three years will take place, at North Korea's Mount Kumgang. The reunion is included in the historic accord that was signed by the leaders of the two Koreas in April. Around 57,000 people were eligible to take part. Of those, 0.16 percent, just 89 people, will make the journey. 1098

LEMON GROVE, Calif. (KGTV) - Supporters of a sales tax increase in Lemon Grove plan to gather signatures for the final time this weekend in hopes of qualifying a ballot measure that they say is needed to save the city from disincorporation.Facing gloomy revenue projections in a city with the lowest sales tax rate in the county, supporters want to put a three-quarter cent increase before voters on the March ballot.Without the hike, the city might be forced to dissolve into the county, which would take possession of city assets and likely sell City Hall, said councilman Jerry Jones."We've done all the cuts that we can do," he said. "We're in worse shape than we were 10 years ago."The city spends roughly 80 percent of its budget on public safety, leaving little for infrastructure and other programs like addressing homelessness, Jones said.The tax hike would generate 3 million dollars, raising the city's total sales tax revenue by 38 percent, he said.At the Grove Grinder restaurant, business owner Sharon Jones is skeptical of the doomsday scenario."I think it's just a scare tactic," she said.She thinks the city should help its business community grow, and says raising the sales tax might do just the opposite."There are more businesses closing down here in lemon grove. If they think they're getting the sales tax that comes from businesses, they're not going to get as much as they think they're going to get," she said.Councilman Jones was once opposed to a tax increase too, but now he say it's necessary."There are just no other alternatives if we want to stay a city," he said.Supporters have until September 30 to gather 1,489 signatures to qualify for the March 2020 ballot."We think we can" get enough signatures by the deadline, said Yadira Altamirano, one of the proponents of the Lemon Grove Tax Measure. "We need all of our neighbors and Lemon Grove registered voters to come sign the petition this weekend."Organizers will be collecting signatures in the Sprouts parking lot Saturday from 9 a.m. until 1 p.m. and Sunday from 3 p.m. to 7 p.m., she said.If the measure doesn't qualify for the March ballot, the council could step in and vote to put a measure on the November ballot, Councilman Jones said. 2239

LEMON GROVE (KGTV) - Fire crews snuffed out a brush fire near Imperial Avenue and San Altos Place in Lemon Grove Sunday evening. Heartland Fire said the blaze started shortly after 5 p.m. when a palm tree caught fire near trolley tracks. Trolley service was disrupted near the Massachusetts Avenue station and busses were used to transport passengers.The fire threatened about 20 homes, and no one was evacuated. Some power lines were damaged, along with railroad ties to the trolley. The fire also damaged a residential fence and the eaves of a few homes.Nobody was injured in the fire, which was contained in about 40 minutes by several fire crews, including a water-dropping helicopter.The San Diego Sheriff's Bomb and Arson Unit is investigating the cause of the fire. 815

LAS VEGAS — For the first time in 20 years, the Food and Drug Administration has approved a new drug for the treatment of the flu.  The antiviral drug, called Xofluza, is a single dose treatment.  It is for patients who are 12 or older.  The drug must be taken within 48 hours of symptoms, according to the F.D.A. "Very exciting that we have another drug on the market," said Dr. Daliah Wachs.Xofluza is said to be as effective as Tamiflu in alleviating symptoms.  "Do I think it's a lifesaver? Potentially yes," said Dr. Wachs.Unlike earlier drugs, Xofluza is expected to work against drug-resistant strains. It will also shorten the length of the flu."The longer you have the flu, the more you are at risk for complications," said Dr. Wachs.Doctors say it is still critically important for everyone to get vaccinated, especially children and the elderly.  900

Last year's seasonal flu vaccine effectiveness was just 42%, the US Centers for Disease Control and Prevention estimated. Even if vaccinated, then, people had inadequate protection against the flu.This limited effectiveness was due to a mutation that occurred in the influenza A (H3N2) vaccine strain, according to a new study published Monday in the journal Proceedings of the National Academy of Sciences. This vaccine mutation resulted from an egg-based manufacturing process commonly used today.This year's flu vaccine may also be imperfect, said Scott Hensley, author of the new study and an associate professor at the University of Pennsylvania. Add to that, he said, "this could end up being a pretty bad flu season."Still, he said, "our best protection" against severe illness is getting vaccinated with the flu shot we have today.Finding answersEach year before flu season begins, a vaccine is made based on whichever virus strains are expected to circulate. The selected seed strains are distributed to vaccine manufacturers which then produce their formulations and make them available to health care professionals before the season begins.During the 2015-16 season, vaccine effectiveness was 47%, while for the previous 2014-15 season, effectiveness was just 19%, according to the CDC. While the overall effectiveness of last season's vaccine was 42%, it was only 34% effective against the H3N2 viruses that dominated the season.Vaccine effectiveness varies based on how well it matches the circulating virus strains. Sometimes, a vaccine corresponds to the predominant virus yet its effectiveness is still not what scientists would expect. Trying to understand which element of the vaccine failed is difficult.Hensley and his team began their investigation of last year's vaccine by looking at the seed strains that had been distributed to vaccine manufacturers. These seed strains had been propagated in chicken eggs, the common method used today."The sequences of these viruses are available and when we did an alignment to see what the sequence of these vaccines were compared to the viruses that were circulating, it became very obvious that there was this mutation," said Hensley.To see the effects of the mutation, the team next looked at how the immune systems of both animals and humans who'd been inoculated with an egg-based flu vaccine responded to the actual circulating viruses.The antibodies -- immune system proteins that fight invading pathogens -- elicited in both animals and humans failed to bind to and neutralize the flu viruses, Hensley and his colleagues found.While most vaccines in the United States are made in chicken eggs, a small fraction are produced in insects or mammalian cells, Hensley explained. (These are given to people with egg allergies.) He and his team compared immune responses in animals and humans who had received a cell-based vaccine -- in this case, Flublok made by Protein Sciences Corporation."And we found both animals and humans receiving that (cell-based) vaccine had superior antibody responses that could bind and neutralize these circulating H3N2 strains," said Hensley.Making a better vaccine"Most of the infrastructure to produce vaccines in the US is based on chicken eggs," said Hensley. There are good reasons for this, including the fact that egg-based propagation allows manufacturers to quickly produce large quantities of vaccine.While egg adaptations have always been a problem, beginning last year it had become a "huge problem," said Hensley. "As soon as you try to grow this virus in eggs, within a few hours, the virus will acquire this kind of mutation."This is not an easy problem to fix, he said. To produce vaccines in cells means "a very expensive process for companies to just change their overall manufacturing process," Hensley explained. "You can't really do that on the drop of a dime."Meanwhile, the same seed strains used last year are being used this year to make the current vaccine, said Hensley."This year may be especially difficult because, in addition to this egg adaptive mutation which was present last year, there's indication that the H3N2 viruses are actually evolving," said Hensley.Not only will the vaccine be a mismatch with the actual circulating viruses due to egg adaptation but the vaccine could also be a mismatch due to unexpected viral evolution.What kind of flu season is ahead?It's too early to speculate which viruses will become dominant in the United States over the course of the coming flu season, said Hensley, "but it's starting to look like it will be H3 viruses." H3 viruses are influenza A viruses."There are the A group of viruses and the B groups," said Dr. William Schaffner, an infectious disease specialist at Vanderbilt University. "The A groups are the ones that usually are responsible for large epidemics ... whereas the B flu strains usually smolder along. They always cause illness -- it can be just as severe as the A strains -- but they don't produce large outbreaks."Though last year's vaccine was mostly ineffective in thwarting the flu, it still prevented nearly 30% of hospitalizations that might have resulted, according to CDC calculations. For older adults, that rate was even higher, at 37%. Plus, the vaccine reduced outpatient visits by 42% last season.The CDC advises everyone 6 months and older to get a flu shot, as only injectable flu vaccines are recommended. More than 130 million doses of flu vaccine have been distributed so far this year and flu activity is still low across the nation.It's still early days, but experts believe we may be facing a tough season, and not only because of vaccine concerns.The reason?Australia had a tough flu season this year, with a total of 215,280 laboratory-confirmed cases and 504 flu-associated deaths reported to its National Notifiable Diseases Surveillance System as of October 13, government data show. According to a surveillance system report, adults over the age of 80 and children between 5 and 9 years old have been most affected."In general, we get in our season what the Southern Hemisphere got in the season immediately preceding us," Dr. Anthony Fauci, director of the United States' National Institute of Allergy and Infectious Diseases, said in an interview last month.An "intelligent guess," therefore, is that the Northern Hemisphere, like the Southern Hemisphere, will likely battle more cases of the viral infection, he said, though "with influenza, it is never 100%.""If H3N2 viruses dominate the US flu season again this year, vaccine effectiveness will likely be moderate to low again," said Hensley.Still, he said, everyone should get their annual flu shot."The other components of the vaccine, like H1N1 and influenza B, will likely provide excellent protection," said Hensley. "The vaccine will also likely prevent severe disease and death caused by H3N2 viruses, even though this component of the vaccine is mismatched."  6969